Whole-body CT reduces trauma-related deaths
Seriously injured patients have a better chance of surviving multiple trauma when they are evaluated in the emergency room with whole-body CT, according to a study of more than 4500 cases from Germany.
Seriously injured patients have a better chance of surviving multiple trauma when they are evaluated in the emergency room with whole-body CT, according to a study of more than 4500 cases from Germany.
Dr. Stefan Huber-Wagner and colleagues at the Munich University Hospital's department of trauma surgery compared the probability of survival in patients with blunt multiple trauma who underwent whole-body CT during resuscitation with those who did not. The investigators reviewed data from 4621 patients from several trauma centers recorded by the German Trauma Society’s registry. Using two different standard injury assessment methods, they found that polytrauma patients who underwent whole-body scans could achieve up to a 25% lower mortality risk than those who did not undergo whole-body CT. The researchers published results in the April 25 issue of The Lancet.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
